Alzheimer’s disease

Newest contribution to Breaking News is by Dementia Panel: Tackling challenges in care of Alzheimer’s disease and other dementias amid the COVID-19 pandemic, now and in the future

Summer School Health and Wealth WEB Seminars – Converging pathways in Alzheimer and Parkinson’s disease: management strategies and disease modifying treatment

Alzheimer Europe’s 30th Annual Conference #30AEC, which was planned to take place in Bucharest, will now be a virtual conference, under the banner “Dementia in a changing world”

On September 25th , EBC held its latest event in the European Parliament, this time building on the Value of Treatment‘s work on Alzheimer’s and The Socioeconomic impact of Alzheimer’s in Europe. This event was an opportunity to further present… Continue Reading

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

  The year’s BRAIN prize was awarded to Professors Bart de Strooper (Leuven),Christian Haass (Munich), Michael Goedert (Cambridge) and John Hardy (London) for their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease, with far-reaching implications for the… Continue Reading

      by Anna Sauerbier     The societal impact of pain (SIP) 2017 Steering Committee Meeting New techniques target protein clumps linked to Alzheimer’s and cancer Inside the solitary life of an Alzheimer’s sufferer E-health Tallinn 2017: i-prognosis… Continue Reading

It is a great pleasure to introduce the recipients of the Research Fellowship 2018 (in alphabetical order):

It is not new that human disease is imposing a burden on the sufferers and a challenge for the physician. While neurologists are having the privilege being physicians and have the single patient in our focus of attention, health economists take a different view. Their thinking is focusing on the burden of disease for the society and its economic implications. They look at the costs of disease in different terms. The classical measures for the burden of disease are the costs in terms of disability-adjusted life years (DALYs) which are defined as the sum of years of life lost due to the disease (YLLs) and years lived with the disease (YLDs) accounting for reduced life time with good quality of life due to the disability. Another important measure is the Socio-demographic Index (SDI) reflecting economic and educational development. There is big science behind all these calculations which I will not go into detail here.

  SP on Dementia and Cognitive Disorders Panel met during recent EAN Congress in Amsterdam. Co-chairs Reinhold Schmidt from Austria and Jakub Hort from Czech Republic welcomed members and announced that Prof. Dafin Muresanu from Romania has been appointed as… Continue Reading

Report from Dr Célia Carina Machado, from Oliveira Santa Maria, Portugal visiting the Department of Epilepsy, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK, under the supervision of Prof. Ley Sander

Residents and research fellows discover the VUmc This year’s annual hospital visit on Sunday 25th of June 2017 brought 80 residents and research fellows from all over the world to the impressive VU University Medical Center Amsterdam (VUmc) located in the southwestern part of Amsterdam, close to the campus of VU University. The RRFS hospital visit was organised in collaboration with the Dutch Junior Neurology Association.